Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(13 sites)

United States

UCSF Benioff Children's Hospital, Oakland, California

Johns Hopkins University, Baltimore, Maryland

University of Wisconsin Madison - Waisman Center Bone Dysplasia Clinic, Madison, Wisconsin

Australia

Murdoch Children's Research Institute, Parkville, Victoria

Canada

Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario